Summary
A breast cancer study has been started in memory of Sarah Harding, a singer from the group Girls Aloud, who passed away from the disease in 2021. The study, funded by the Sarah Harding Breast Cancer Appeal, focuses on breast cancer in women in their 30s and is conducted at the Christie Hospital in Manchester. Dr. Hannah Harrison leads the research to find better prevention and treatment for young women with breast cancer.
Key Facts
- Sarah Harding, a member of Girls Aloud, died from breast cancer in 2021 at age 39.
- The Sarah Harding Breast Cancer Appeal funds research in her memory.
- The study is conducted at the Christie Hospital in Manchester, where Harding was treated.
- Dr. Hannah Harrison is leading the study as the Sarah Harding Young Women's Breast Cancer Fellow.
- The research focuses on risk factors for breast cancer in women in their 30s.
- The goal is to enable breast cancer risk assessments for all women by age 30.
- The study aims to understand why current prevention drugs do not work for all women.
